複数の海外メディアで紹介されました。 | Middle Molecule IT-based Drug Discovery Laboratory

The "Program to Industrialize an Innovative Middle Molecule Drug Discovery Flow through Fusion of Computational Drug Design and Chemical Synthesis Technology," which were supported from MEXT with "Program for Building Regional Innovation Ecosystems" has finished on March 31st, 2022. The contents for the program are archived here.
The Middle Molecule IT-based Drug Discovery Laboratory (MIDL) is still running as one of the "Innovation Research Initiatives" at Tokyo Institute of Technology. New information is uploaded on the new website.

05/26/2021 - 12:00

「地域イノベーション・エコシステム形成プログラム」での取り組みや、ファスタイド株式会社の設立が、海外のメディアで紹介されました。

Bioengineer.org
"Fastide, Inc. established to commercialize results of middle molecule drug discovery"

Plato
"Fastide, Inc. established to commercialize results of middle molecule drug discovery"

News Break
"Fastide, Inc. established to commercialize results of middle molecule drug discovery"

ScienMag
"Fastide, Inc. established to commercialize results of middle molecule drug discovery"